Tag Archives: drugs

Hurting for revenue, Mylan shells out $130M for basket of Aspen drugs

With share prices tumbling and a massive drug-price fixing lawsuit hanging over its head, Mylan’s future is looking increasingly spooky. Could a modest acquisition help turn the tide? It’s willing to try and find out. The Pennsylvania drugmaker will shell out $ 130 million for Aspen Pharmacare’s portfolio of prescription and over-the-counter products in Australia and New… Read More »

Novartis sees Saudi Arabia as promising market for producing its cancer drugs

Novartis may be struggling a bit in the U.S. with cancer drug launches, but it has a new market it can now explore––Saudi Arabia. The Swiss drugmaker has signed off on a memorandum of understanding with Sudair Pharma for a technology transfer that would allow the Saudi Arabian company to produce a number of “innovative”… Read More »

FDA head resigns after clearing slew of drugs, fighting e-cigs

Scott Gottlieb, the U.S. Food and Drug Administration Commissioner, ending a tenure where he approved more drugs and pushed for sharp curbs on e-cigarettes. Gottlieb earned a reputation as an attentive and media-savvy regulator in a Trump administration that’s taken a more hands-off approach in many other areas of oversight. A medical doctor, Gottlieb won… Read More »